FY2024 Earnings Forecast for Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Issued By KeyCorp

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities research analysts at KeyCorp issued their FY2024 earnings per share (EPS) estimates for shares of Acadia Healthcare in a report issued on Thursday, October 10th. KeyCorp analyst M. Gillmor anticipates that the company will post earnings of $3.51 per share for the year. KeyCorp has a “Sector Weight” rating on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.51 per share. KeyCorp also issued estimates for Acadia Healthcare’s FY2025 earnings at $3.86 EPS and FY2026 earnings at $4.47 EPS.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The firm had revenue of $796.00 million during the quarter, compared to analyst estimates of $784.38 million. During the same quarter in the previous year, the business earned $0.92 EPS. The business’s revenue was up 8.8% on a year-over-year basis.

Other research analysts have also issued research reports about the stock. Barclays cut their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Friday, September 20th. Deutsche Bank Aktiengesellschaft lifted their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 1st. One analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and a consensus target price of $86.67.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC opened at $56.96 on Monday. Acadia Healthcare has a 12 month low of $53.22 and a 12 month high of $87.77. The company has a market cap of $5.28 billion, a P/E ratio of -406.86, a P/E/G ratio of 1.57 and a beta of 1.29. The business’s 50 day moving average is $71.64 and its two-hundred day moving average is $69.88. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60.

Institutional Trading of Acadia Healthcare

Hedge funds have recently modified their holdings of the company. Point72 Asset Management L.P. increased its stake in shares of Acadia Healthcare by 266.0% in the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock valued at $153,339,000 after buying an additional 1,650,040 shares in the last quarter. Millennium Management LLC lifted its position in shares of Acadia Healthcare by 3,067.8% during the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock worth $73,640,000 after purchasing an additional 1,055,894 shares in the last quarter. William Blair Investment Management LLC grew its stake in shares of Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after purchasing an additional 604,070 shares during the last quarter. Vaughan Nelson Investment Management L.P. increased its holdings in shares of Acadia Healthcare by 67.9% in the second quarter. Vaughan Nelson Investment Management L.P. now owns 733,505 shares of the company’s stock valued at $49,541,000 after purchasing an additional 296,625 shares in the last quarter. Finally, Principal Financial Group Inc. raised its position in Acadia Healthcare by 59.3% in the 1st quarter. Principal Financial Group Inc. now owns 539,162 shares of the company’s stock worth $42,712,000 after purchasing an additional 200,765 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.